-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JlL8nAtvXdXDzE0FFHsV0RD1vg0j7kdlGgZMqm0G8W72NSog8DVMnGtlu3KfNAcp mnqtJwtt8kWFO3ANcUhLiA== 0001181431-09-017397.txt : 20090326 0001181431-09-017397.hdr.sgml : 20090326 20090326130757 ACCESSION NUMBER: 0001181431-09-017397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090325 FILED AS OF DATE: 20090326 DATE AS OF CHANGE: 20090326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGE LOUIS G CENTRAL INDEX KEY: 0001238401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21643 FILM NUMBER: 09706058 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 rrd238263.xml FORM 4 LOUIS G LANGE MARCH 25, 2009 RSU DISTRIBUTION X0303 4 2009-03-25 0 0000921506 CV THERAPEUTICS INC CVTX 0001238401 LANGE LOUIS G 3172 PORTER DRIVE PALO ALTO CA 94304 1 1 0 0 Chairman & CEO Common Stock 2009-03-25 4 M 0 10052 19.88 A 345720 D Common Stock 2009-03-25 4 F 0 4453 19.88 D 341267 D Common Stock 2009-03-25 4 M 0 1293 19.88 A 342560 D Common Stock 2009-03-25 4 F 0 572 19.88 D 341988 D Common Stock 6359.8935 I By 401(k) Restricted Stock Units 2009-03-25 4 M 0 10052 0 D 2005-12-22 2009-12-22 Common Stock 10052 100519 D Restricted Stock Units 2009-03-25 4 M 0 1293 0 D 2006-03-22 2009-12-22 Common Stock 1293 12934 D Shares held in the Reporting Person's name by the Issuer's 401(k) plan. Upon payout, the Reporting Person is entitled to receive 1 share of common stock for each 1 restricted stock unit. 20,169 shares of this grant vested effective December 22, 2005; 5.554% of the shares of common stock subject to this grant shall vest at the end of each three month period (each a "Vesting Date") commencing on December 22, 2005, such that 100% of the shares of common stock subject to the restricted stock units are vested on December 22, 2009. Shares of common stock subject to any restricted stock units that vest shall be distributed to the Reporting Person in whole shares of common stock on each twelve (12) month anniversary of their relevant Vesting Date. The shares subject to this grant commenced vesting as of December 22, 2005; 6.25% of the shares of common stock subject to this grant shall vest at the end of each three month period (each a "Vesting Date") commencing on December 22, 2005, such that 100% of the shares of common stock subject to the restricted stock units are vested on December 22, 2009. Shares of common stock subject to any restricted stock units that vest shall be distributed to the Reporting Person in whole shares of common stock on each twelve (12) month anniversary of their relevant Vesting Date. Tricia Borga Suvari, Attorney-in Fact for : Louis G. Lange 2009-03-25 -----END PRIVACY-ENHANCED MESSAGE-----